EZM-8266

N/A

Report date: 2022/08/23 20:00:44
NME

Base Information

Drug NameEZM-8266
Drug Alias NameEZM8266
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone-lysine N-methyltransferase EHMT2 inhibitors
TargetsHistone-lysine N-methyltransferase EHMT2
Therapy Area/IndicationsAnemia, Sickle Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEpizyme Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEpizyme Inc
Active IndicationsN/A
Inactive IndicationsAnemia, Sickle Cell

Other Information

ATC CodeN/A
Related LinksN/A